Claritev Operating Margin 2019-2024 | CTEV
Current and historical operating margin for Claritev (CTEV) over the last 10 years. The current operating profit margin for Claritev as of December 31, 2024 is -20.72%.
| Claritev Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-12-31 | $0.93B | $-1.39B | -149.35% |
| 2024-09-30 | $0.94B | $-1.31B | -138.75% |
| 2024-06-30 | $0.96B | $-0.93B | -97.28% |
| 2024-03-31 | $0.96B | $-0.37B | -38.54% |
| 2023-12-31 | $0.96B | $0.16B | 16.94% |
| 2023-09-30 | $0.96B | $-0.49B | -51.30% |
| 2023-06-30 | $0.97B | $-0.50B | -51.35% |
| 2023-03-31 | $1.02B | $-0.43B | -42.53% |
| 2022-12-31 | $1.08B | $-0.36B | -33.64% |
| 2022-09-30 | $1.14B | $0.36B | 31.78% |
| 2022-06-30 | $1.17B | $0.43B | 36.54% |
| 2022-03-31 | $1.16B | $0.42B | 36.29% |
| 2021-12-31 | $1.12B | $0.39B | 34.56% |
| 2021-09-30 | $1.07B | $0.24B | 21.97% |
| 2021-06-30 | $1.01B | $-0.07B | -6.73% |
| 2021-03-31 | $0.94B | $-0.14B | -14.67% |
| 2020-12-31 | $0.94B | $-0.13B | -14.07% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.351B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.567B | 53.27 |
| Hims & Hers Health (HIMS) | United States | $11.630B | 120.84 |
| Tempus AI (TEM) | United States | $10.569B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.461B | 69.70 |
| IRhythm Technologies (IRTC) | United States | $4.396B | 0.00 |
| Privia Health (PRVA) | United States | $3.050B | 208.50 |
| Enovis (ENOV) | United States | $1.888B | 10.52 |
| Clover Health Investments (CLOV) | United States | $1.793B | 0.00 |
| Schrodinger (SDGR) | United States | $1.746B | 0.00 |
| Phreesia (PHR) | United States | $1.506B | 0.00 |
| Azenta (AZTA) | United States | $1.223B | 56.96 |
| Omnicell (OMCL) | United States | $1.208B | 21.31 |
| 10x Genomics (TXG) | United States | $1.073B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.600B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.509B | 151.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.371B | 827.00 |
| Health Catalyst (HCAT) | United States | $0.290B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.107B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.089B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.088B | 0.00 |
| CareCloud (CCLD) | United States | $0.081B | 3.07 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |